Title |
Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
|
---|---|
Published in |
Trials, January 2013
|
DOI | 10.1186/1745-6215-14-23 |
Pubmed ID | |
Authors |
Babak Choodari-Oskooei, Mahesh KB Parmar, Patrick Royston, Jack Bowden |
Abstract |
In 2011, Royston et al. described technical details of a two-arm, multi-stage (TAMS) design. The design enables a trial to be stopped part-way through recruitment if the accumulating data suggests a lack of benefit of the experimental arm. Such interim decisions can be made using data on an available 'intermediate' outcome. At the conclusion of the trial, the definitive outcome is analyzed. Typical intermediate and definitive outcomes in cancer might be progression-free and overall survival, respectively. In TAMS designs, the stopping rule applied at the interim stage(s) affects the sampling distribution of the treatment effect estimator, potentially inducing bias that needs addressing. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 43% |
Netherlands | 1 | 14% |
India | 1 | 14% |
Unknown | 2 | 29% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 71% |
Scientists | 1 | 14% |
Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
France | 1 | 3% |
Unknown | 29 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 14 | 45% |
Student > Ph. D. Student | 5 | 16% |
Other | 4 | 13% |
Professor | 1 | 3% |
Student > Master | 1 | 3% |
Other | 1 | 3% |
Unknown | 5 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 39% |
Mathematics | 8 | 26% |
Nursing and Health Professions | 1 | 3% |
Decision Sciences | 1 | 3% |
Economics, Econometrics and Finance | 1 | 3% |
Other | 2 | 6% |
Unknown | 6 | 19% |